Oxidative stress after preterm birth: Origins, biomarkers, and possible therapeutic approaches;Stress oxydant chez l'enfant prématuré: Causes, biomarqueurs et possibilités thérapeutiques

Archives de Pediatrie

Volumn 22, Issue 10, 2015, Pages 1047-1055

  Yzydorczyk, C ^a,b   Mitanchez, D ^c,d   Buffat, C ^e   Ligi, I ^e   Grandvuillemin, I ^e   Boubred, F ^e   Simeoni, U ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; HEMOGLOBIN; MALONALDEHYDE; MELATONIN; OXYGEN; 4-HYDROXY-2-NONENAL; ADVANCED OXIDATION PROTEIN PRODUCT; ALDEHYDE; ANTIOXIDANT; ISOPROSTANE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; BREAST FEEDING; EXPERIMENTAL STUDY; HUMAN; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXIDATIVE STRESS; OXYGEN SATURATION; OXYGEN SUPPLY; PREMATURE LABOR; SHORT SURVEY; ADVERSE EFFECTS; DELIVERY ROOM; FEMALE; METABOLISM; NEWBORN; OXYGEN THERAPY; PARENTERAL NUTRITION; PREGNANCY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY;

ADVANCED OXIDATION PROTEIN PRODUCTS; ALDEHYDES; ANTIOXIDANTS; BIOMARKERS; BREAST FEEDING; DELIVERY ROOMS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; ISOPROSTANES; MALONDIALDEHYDE; MELATONIN; OXIDATIVE STRESS; OXYGEN INHALATION THERAPY; PARENTERAL NUTRITION; PREGNANCY; REACTIVE OXYGEN SPECIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY;

EID: 84942552774     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2015.05.019     Document Type: Short Survey

References (50)

1. Saugstad O.D. Optimal oxygenation at birth and in the neonatal period. Neonatology 2007, 91:319-322.
2. Vento M., Moro M., Escrig R., et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009, 124:e439-e449.
3. Stenson B.J., Tarnow-Mordi W.O., Darlow B.A., et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013, 368:2094-2104.
4. Carlo W.A., Finer N.N., Walsh M.C., et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010, 362:1959-1969.
5. Schmidt B., Whyte R.K., Asztalos E.V., et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013, 309:2111-2120.
6. Yeung M.Y. Influence of early postnatal nutritional management on oxidative stress and antioxidant defence in extreme prematurity. Acta Paediatr 2006, 95:153-163.
7. Chessex P., Watson C., Kaczala G.W., et al. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med 2010, 49:1380-1386.
8. Saugstad O.D. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988, 23:143-150.
9. Niesman M.R., Johnson K.A., Penn J.S. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res 1997, 22:597-605.
10. Georgeson G.D., Szony B.J., Streitman K., et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 2002, 103:136-139.
11. Baydas G., Karatas F., Gursu M.F., et al. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res 2002, 33:276-280.
12. Dommergues M.A., Gallego J., Evrard P., et al. Iron supplementation aggravates periventricular cystic white matter lesions in newborn mice. Eur J Paediatr Neurol 1998, 2:313-318.
13. Lindeman J.H., Lentjes E.G., van Zoeren-Grobben D., et al. Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies. Biol Neonate 2000, 78:73-76.
14. McDonald S.J., Middleton P., Dowswell T., et al. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2013, 7. [CD004074].
15. Myatt L., Brewer A., Brockman D.E. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991, 164:687-692.
16. Davis J.M., Auten R.L. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010, 15:191-195.
17. Qanungo S., Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000, 215:11-19.
18. Zavalza-Gomez A.B. Obesity and oxidative stress: a direct link to preeclampsia?. Arch Gynecol Obstet 2011, 283:415-422.
19. Lanoix D., Guerin P., Vaillancourt C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy. J Pineal Res 2012, 53:417-425.
20. Saben J., Lindsey F., Zhong Y., et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014, 35:171-177.
21. Li H.P., Chen X., Li M.Q. Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int J Clin Exp Pathol 2013, 6:650-659.
22. Coughlan M.T., Vervaart P.P., Permezel M., et al. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 2004, 25:78-84.
23. Yin B., Zhen M. Lipid peroxidation in plasma and the activity of superoxide dismutase (SOD) in pregnant women with premature rupture of membrane. Zhonghua Yi Xue Za Zhi 1995, 75. 463-5, 509.
24. Inder T.E., Darlow B.A., Sluis K.B., et al. The correlation of elevated levels of an index of lipid peroxidation (MDA-TBA) with adverse outcome in the very low birthweight infant. Acta Paediatr 1996, 85:1116-1122.
25. Weinberger B., Anwar M., Henien S., et al. Association of lipid peroxidation with antenatal betamethasone and oxygen radial disorders in preterm infants. Biol Neonate 2004, 85:121-127.
26. Ates O., Alp H.H., Caner I., et al. Oxidative DNA damage in retinopathy of prematurity. Eur J Ophthalmol 2009, 19:80-85.
27. Cipierre C., Hays S., Maucort-Boulch D., et al. Malondialdehyde adduct to hemoglobin: a new marker of oxidative stress suitable for full-term and preterm neonates. Oxid Med Cell Longev 2013, 2013:694014.
28. Ogihara T., Hirano K., Morinobu T., et al. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999, 80:F21-F25.
29. Comporti M., Signorini C., Leoncini S., et al. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004, 37:724-732.
30. Friel J.K., Diehl-Jones B., Cockell K.A., et al. Evidence of oxidative stress in relation to feeding type during early life in premature infants. Pediatr Res 2011, 69:160-164.
31. Franco M.C., Kawamoto E.M., Gorjao R., et al. Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr Res 2007, 62:204-208.
32. Buonocore G., Perrone S., Longini M., et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res 2002, 52:46-49.
33. Banks B.A., Ischiropoulos H., McClelland M., et al. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998, 101:870-874.
34. Cunningham A.S. Breast-feeding, antioxidants, and retinopathy of prematurity. Am J Obstet Gynecol 1987, 156:1040-1041.
35. Aycicek A., Erel O., Kocyigit A., et al. Breast milk provides better antioxidant power than does formula. Nutrition 2006, 22:616-619.
36. Shoji H., Shimizu T., Shinohara K., et al. Suppressive effects of breast milk on oxidative DNA damage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004, 89:F136-F138.
37. Ledo A., Arduini A., Asensi M.A., et al. Human milk enhances antioxidant defenses against hydroxyl radical aggression in preterm infants. Am J Clin Nutr 2009, 89:210-215.
38. Miranda M., Muriach M., Almansa I., et al. Oxidative status of human milk and its variations during cold storage. Biofactors 2004, 20:129-137.
39. Silvestre D., Miranda M., Muriach M., et al. Frozen breast milk at-20 degrees C and-80 degrees C: a longitudinal study of glutathione peroxidase activity and malondialdehyde concentration. J Hum Lact 2010, 26:35-41.
40. Silvestre D., Miranda M., Muriach M., et al. Antioxidant capacity of human milk: effect of thermal conditions for the pasteurization. Acta Paediatr 2008, 97:1070-1074.
41. Ambalavanan N., Tyson J.E., Kennedy K.A., et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005, 115:e249-e254.
42. Darlow B.A., Graham P.J. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007, [CD000501].
43. Brion L.P., Bell E.F., Raghuveer T.S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003, [CD003665].
44. Gadhia M.M., Cutter G.R., Abman S.H., et al. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr 2014, 164:744-748.
45. Reiter R.J., Tan D.X., Terron M.P., et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007, 54:1-9.
46. Pan L., Fu J.H., Xue X.D., et al. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr 2009, 5:216-221.
47. Biran V., Phan Duy A., Decobert F., et al. Is melatonin ready to be used in preterm infants as a neuroprotectant?. Dev Med Child Neurol 2014, 56:717-723.
48. Fulia F., Gitto E., Cuzzocrea S., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31:343-349.
49. Chang L.Y., Subramaniam M., Yoder B.A., et al. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2003, 167:57-64.
50. Davis J.M., Parad R.B., Michele T., et al. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003, 111:469-476.